Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial

The Lancet Oncology 2026

View at publisher
Authors: Akihiro Ito, Yoichi Arai, Yoshiyuki Kakehi, Masayuki Yokoyama, Keita Sasaki, Motohide Uemura, Atsushi Takahashi, Kazuo Nishimura, Takashi Kawahara, Hitoshi Masuda, Koji Yoshimura, Takashi Kobayashi
+12 more Masatoshi Eto, Tsukasa Igawa, Naotaka Nishiyama, Takanori Mochizuki, Akira Yokomizo, Makito Miyake, Tomohiko Ichikawa, Katsuyoshi Hashine, Takuma Sato, Mikio Sugimoto, Hiroyuki Nishiyama, Hiroshi Kitamura
DOI: 10.1016/s1470-2045(26)00130-0
Cited by: 1
References: 26

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Urinary Tract Infections Management

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
8
Pages
973–982
Publication date
11 July 2026
Language
EN